| Primary |
| Abscess Intestinal |
13.6% |
| Infection |
11.4% |
| Abscess Drainage |
9.1% |
| Mycobacterial Infection |
9.1% |
| Post Procedural Infection |
9.1% |
| Mycobacterium Abscessus Infection |
6.8% |
| Product Used For Unknown Indication |
6.8% |
| Anti-infective Therapy |
4.5% |
| Antibiotic Prophylaxis |
4.5% |
| Appendicitis Perforated |
4.5% |
| Peridiverticular Abscess |
4.5% |
| Bacterial Infection |
2.3% |
| Cellulitis |
2.3% |
| Colon Operation |
2.3% |
| Cystic Fibrosis |
2.3% |
| Haemorrhoid Operation |
2.3% |
| Pain |
2.3% |
| Prophylaxis |
2.3% |
|
| Catatonia |
8.0% |
| Pain In Extremity |
8.0% |
| Pancytopenia |
8.0% |
| Rash Pruritic |
8.0% |
| Tetany |
8.0% |
| Blood Creatinine Increased |
4.0% |
| Clostridium Difficile Colitis |
4.0% |
| Infusion Related Reaction |
4.0% |
| Intercepted Medication Error |
4.0% |
| Leukocytoclastic Vasculitis |
4.0% |
| Myoclonus |
4.0% |
| Ocular Icterus |
4.0% |
| Post Procedural Complication |
4.0% |
| Product Contamination Physical |
4.0% |
| Pulmonary Tuberculosis |
4.0% |
| Rash |
4.0% |
| Rash Maculo-papular |
4.0% |
| Sepsis |
4.0% |
| Tachycardia |
4.0% |
| Toxicity To Various Agents |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
13.1% |
| Drug Use For Unknown Indication |
10.1% |
| Pharyngitis Streptococcal |
7.3% |
| Mycobacterium Abscessus Infection |
7.0% |
| Abscess Intestinal |
6.7% |
| Prophylaxis |
6.1% |
| Abdominal Infection |
5.8% |
| Infection Prophylaxis |
5.5% |
| Infection |
4.3% |
| Pyrexia |
4.3% |
| Pain |
4.0% |
| Multiple Myeloma |
3.7% |
| Mycobacterial Infection |
3.4% |
| Antibiotic Therapy |
3.1% |
| Appendicitis Perforated |
3.1% |
| Eczema |
2.8% |
| Anxiety |
2.4% |
| Nausea |
2.4% |
| Pneumonia |
2.4% |
| Vomiting |
2.4% |
|
| Toxic Epidermal Necrolysis |
19.6% |
| Renal Failure |
9.8% |
| Renal Failure Acute |
7.8% |
| Death |
5.9% |
| Sepsis |
5.9% |
| Tetany |
5.9% |
| Catatonia |
3.9% |
| Clostridial Infection |
3.9% |
| Condition Aggravated |
3.9% |
| Electrocardiogram Abnormal |
3.9% |
| Leukopenia |
3.9% |
| Neurotoxicity |
3.9% |
| Pseudomonas Test Positive |
3.9% |
| Rash Pruritic |
3.9% |
| Tremor |
3.9% |
| Anaphylactic Shock |
2.0% |
| Blood Creatinine Increased |
2.0% |
| Cardiac Arrest |
2.0% |
| Clostridium Difficile Colitis |
2.0% |
| Dehydration |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.0% |
| Product Used For Unknown Indication |
10.7% |
| Pain |
8.3% |
| Antibiotic Prophylaxis |
7.1% |
| Neoplasm Malignant |
5.9% |
| Atypical Mycobacterial Infection |
5.3% |
| Anaesthesia |
3.6% |
| Contraception |
3.6% |
| General Anaesthesia |
3.6% |
| Inflammatory Bowel Disease |
3.3% |
| Mechanical Ventilation |
3.3% |
| Hyperglycaemia |
3.0% |
| Mycobacterial Infection |
3.0% |
| Nausea |
2.7% |
| Parkinson's Disease |
2.7% |
| Hypertension |
2.4% |
| Metastases To Bone |
2.1% |
| Prophylaxis Against Transplant Rejection |
2.1% |
| Asthma |
1.8% |
| Breast Cancer |
1.8% |
|
| Renal Failure Acute |
11.1% |
| Diverticulitis |
9.3% |
| Cholecystitis |
5.6% |
| Drug Ineffective |
5.6% |
| Status Epilepticus |
5.6% |
| Thrombophlebitis Superficial |
5.6% |
| Urinary Tract Infection |
5.6% |
| Weight Decreased |
5.6% |
| Wheezing |
5.6% |
| Abdominal Pain |
3.7% |
| Cholecystitis Acute |
3.7% |
| Colitis Ulcerative |
3.7% |
| Dyspepsia |
3.7% |
| Hepatitis Acute |
3.7% |
| Hypersensitivity |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Leukocytoclastic Vasculitis |
3.7% |
| Myocardial Infarction |
3.7% |
| Pain |
3.7% |
| Peptic Ulcer |
3.7% |
|
